Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome. Dermatology Reports, [S. l.], v. 3, n. 3, p. e55, 2011. DOI: 10.4081/dr.2011.e55. Disponível em: https://journals.pagepress.org/dr/article/view/dr.2011.e55. Acesso em: 18 jun. 2025.